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Maternal depression is associated with DNA methylation
changes in cord blood T lymphocytes and adult hippocampi
Z Nemoda1,2,9, R Massart1,2, M Suderman1,2,3, M Hallett3, T Li4, M Coote4, N Cody1, ZS Sun5, CN Soares4,6,7, G Turecki8, M Steiner4,6,7 and
M Szyf1,2,3
Depression affects 10–15% of pregnant women and has been associated with preterm delivery and later developmental,
behavioural and learning disabilities. We tested the hypothesis that maternal depression is associated with DNA methylation
alterations in maternal T lymphocytes, neonatal cord blood T lymphocytes and adult offspring hippocampi. Genome-wide DNA
methylation of CD3+ T lymphocytes isolated from 38 antepartum maternal and 44 neonatal cord blood samples were analyzed
using Illumina Methylation 450 K microarrays. Previously obtained methylation data sets using methylated DNA
immunoprecipitation and array-hybridization of 62 postmortem hippocampal samples of adult males were re-analyzed to test
associations with history of maternal depression. We found 145 (false discovery rate (FDR) qo0.05) and 2520 (FDR qo0.1)
differentially methylated CG-sites in cord blood T lymphocytes of neonates from the maternal depression group as compared with
the control group. However, no signiﬁcant DNA methylation differences were detected in the antepartum maternal T lymphocytes
of our preliminary data set. We also detected 294 differentially methylated probes (FDR qo0.1) in hippocampal samples associated
with history of maternal depression. We observed a signiﬁcant overlap (P= 0.002) of 33 genes with changes in DNA methylation in T
lymphocytes of neonates and brains of adult offspring. Many of these genes are involved in immune system functions. Our results
show that DNA methylation changes in offspring associated with maternal depression are detectable at birth in the immune system
and persist to adulthood in the brain. This is consistent with the hypothesis that system-wide epigenetic changes are involved in
life-long responses to maternal depression in the offspring.
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INTRODUCTION
Major depression is one of the most common psychiatric disorders
with a lifetime prevalence rate of 10–20%.1 Not surprisingly, it
ranks among the leading causes of disability and imposes a
signiﬁcant socioeconomic burden to developed countries.2
Women are particularly affected by major depression3 and 10–
15% experience at least one major depressive episode during
pregnancy,4 which is associated with substantial morbidity to both
mother and child.5 Maternal mood disorders or stress during
pregnancy can have prolonged effects on the developing fetus,
resulting in attention and learning deﬁcits during childhood and
mood disorders during adulthood.6 Untreated depression during
pregnancy is one of the strongest predictors of subsequent
postpartum depression, which has negative effects on mother–
child interaction, attachment styles and child development.7,8
There is growing evidence, from both animal and human studies,
suggesting that long-lasting inﬂuences of early-life environment
may be mediated by modiﬁcations of DNA methylation levels.9
One of the best documented environmental risk factors for later
physical and mental health problems is prenatal stress, possibly
through epigenetic programming of the hypothalamic–pituitary–
adrenal axis in the fetus.10 Increasing number of human studies
point to the involvement of epigenetic regulation of the
glucocorticoid receptor gene (NR3C1) in psychological stress. For
example, increased methylation of the NR3C1 promoter was found
in brain hippocampus samples, as well as in leukocytes of adults
with a history of childhood abuse or maltreatment.11,12 In
addition, increased NR3C1 promoter methylation level was
measured in cord blood samples in relation to maternal
depression13 and to pregnancy-related anxiety.14 Interestingly,
the effect of intrauterine exposure to maternal stress on the NR3C1
promoter methylation level was detectable in leukocytes of
adolescents.15 Prenatal exposure to maternal depression was also
related to modiﬁcations of DNA methylation levels of the
serotonin transporter16 or of imprinted genes17 in infants’ cord
blood. As it is impossible to study DNA methylation changes in the
brain of living subjects, the possibility that DNA methylation states
in isolated white blood cell types are associated with behavioral
exposures and neuropsychiatric phenotypes is of extreme
potential clinical signiﬁcance and needs to be explored.
As immune and neuroinﬂammatory dysfunction is associated
with depression,18,19 we targeted lymphocytes in our DNA
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methylation analyses. To reduce the confounding effect of the
different blood cell types, we focused on T lymphocytes, which are
cardinal regulators of neuroimmune mechanisms. We tested the
hypothesis that long-term effects of maternal depression on the
offspring are mediated by epigenetic alterations that occur in the
immune system as well as in the brain. First, we tested whether
maternal depression is associated with DNA methylation changes
in CD3+ T lymphocytes isolated from maternal blood taken during
pregnancy or neonatal cord blood taken at birth. We then
analyzed DNA methylation data of hippocampal brain tissues from
adults with or without a history of maternal depression.
MATERIALS AND METHODS
Study participants
This study was approved by the Research Ethics Boards of St Joseph’s
Healthcare Hamilton and McGill University, and written informed consent
was obtained from each participant. Altogether, 127 pregnant women
were recruited from outpatients attending the Women’s Health Concern
Clinic and the Obstetrics Department at St Joseph’s Healthcare Hamilton,
Hamilton, ON, Canada. All the participants were 18 years of age or older,
able to communicate in English and planning to deliver at St Joseph’s
Healthcare Hamilton. All the participants were screened for psychiatric
disorders using the Mini-International Neuropsychiatric Interview.20
Participants with current or past history of psychotic disorder, alcohol
and/or drug abuse or dependence were excluded. Furthermore, partici-
pants taking antidepressant medication during pregnancy were not
included in the present analyses. Psychiatric assessments and collection
of venous blood were completed between 24 and 36 weeks of gestation.
Neonatal cord blood samples were collected from the umbilical cord
during delivery.
Psychiatric assessments
Current depressive symptoms were assessed using the Edinburgh
Postnatal Depression Scale and the Montgomery–Asberg Depression
Rating Scale21,22 For the separation of patients in remission, participants
were considered currently symptomatic if they had an Edinburgh Postnatal
Depression Scale score ⩾ 13 (ref. 23) or a Montgomery–Asberg Depression
Rating Scale score ⩾ 9.24 On the basis of their past history and current
symptoms of depression, the nonmedicated participants were classiﬁed
into three groups: The current depression group included all participants
who were symptomatic during pregnancy; the past depression group
included participants who have had major depressive episode(s) in the
past but were not considered currently symptomatic; the control group
included participants who did not have major depression or other
psychiatric disorder.
Preparation of T lymphocyte DNA samples
Whole blood was collected in heparin-coated tubes, stored on ice and
processed within a day of collection. The peripheral blood mononuclear
cell (PBMC) layer was separated by centrifugation with Ficoll-Paque (GE
Healthcare, Little Chalfont, UK) following previously published protocol,25
see details in Supplementary Information S1. CD3+ T lymphocytes were
isolated from the PBMCs with Dynabeads CD3 (111.51D, Invitrogen,
Carlsbad, CA, USA) using a strong magnet (Stemcell Technology,
Vancouver, BC, Canada). When timing did not allow the lymphocyte
isolation to be completed immediately after the PBMC separation, PBMCs
were frozen in 1ml freezing media (RPMI with 20% fetal bovine serum and
10% dimethyl sulfoxide) to be processed at a later time. DNA extraction
was done using the Wizard Genomic DNA Puriﬁcation kit (Promega,
Fitchburg, WI, USA).
Genome-wide DNA methylation analysis
DNA samples of T lymphocytes isolated from 38 blood samples of
pregnant women and from 44 venous cord blood samples were selected
for equal distribution across the three groups (Table 1). The detailed
methods of the methylation analyses can be found in Supplementary
Information S1. Shortly, bisulﬁte conversion of 500 ng genomic DNA was
carried out by EZ-96 DNA Methylation-Gold Kit (D5007, Zymo Research,
Irvine, CA, USA), and microarray experiment using Inﬁnium Human
Methylation 450 K BeadChip Array (WG-314-1001, Illumina, San Diego,
CA, USA) was performed at Genome Quebec, Montreal, QC, Canada. For
the normalization of the array signals and the calculation of M-values
( = log2(methylated signal+1)/(unmethylated signal+1)) the minﬁ Biocon-
ductor package was used.26 To control for the heterogeneity of the sample
handling before lymphocyte isolation, the cell purity of each sample was
estimated using quadratic programming27 and a publicly available Illumina
Methylation 450 K data set (GSE49618) containing methylation proﬁles of
CD3+ T lymphocytes, CD19+ B lymphocytes, CD34+CD38− hematopoietic
stem/progenitor cells and monocytes isolated from human bone
marrow.28 Methylation differences were identiﬁed by applying indepen-
dent surrogate variable analysis as implemented by the ISVA R-package.29
To reduce the number of association tests, only probes with sufﬁciently
high variance across the samples were tested out of the 482 421 probes
measuring CG-sites on the array. These probes had an interquartile range
corresponding to a 10% change in methylation across the samples.
Furthermore, since the cord blood samples were obtained from neonates
of both sexes, probes for chromosomes X and Y were excluded in the cord
blood sample analyses. This was done a priori before any further analyses
were performed, so their removal did not bias downstream analyses. Thus
39 000 and 30 000 probes were chosen for the antepartum maternal and
neonatal cord blood samples, respectively, to test whether there are
differences in DNA methylation between patient and control groups. To
adjust for multiple testing, false discovery rates (FDRs) were calculated
using the Benjamini–Hochberg algorithm.30 Technical variables (such as
Table 1. Selected demographic information of the 44 participants
chosen for the cord blood T lymphocytes’ genome-wide DNA
methylation analyses
Current
depression group
(n= 15)
Past depression
group (n= 14)
Control group
(n= 15)
MADRS 17.5± 6.1 4.6± 2.4 3.4± 3.3
EPDS 13.8± 3.1 5.9± 3.4 4.0± 3.1
Ethnicity
Caucasian 12 (80%) 11 (79%) 13 (87%)
Othera 3 (20%) 3 (21%) 2 (13%)
Mean age (years) 27.0± 5.5 29.6± 5.7 29.8± 4.3
Relationship status
Married/
common-law
9 (60%) 12 (86%) 12 (80%)
Single 6 (40%) 2 (14%) 3 (20%)
Mean pre-
pregnancy BMI
26.1± 10.5 26.1± 6.0 22.6± 4.8
Tobacco use during pregnancy
Yes 6 (40%) 1 (7%) 1 (7%)
No 9 (60%) 13 (93%) 14 (93%)
Mean no. of
pregnanciesb
2.6± 2.2 2.9± 2.1 1.8± 1.2
Mean no. of
childrenb
1.6± 0.9 2.0± 1.2 1.9± 1.3
Mean no. of
weeks gestation
39.7± 1.2 39.3± 1.5 39.5± 1.1
Mode of delivery
Cesarean
section
1 (7%) 7 (50%) 2 (13%)
Vaginal 14 (93%) 7 (50%) 13 (87%)
Sex of infant
Male 7 (47%) 8 (57%) 7 (47%)
Female 8 (53%) 6 (43%) 8 (53%)
Abbreviations: BMI, body mass index; EPDS, Edinburgh Postnatal Depres-
sion Scale; MADRS, Montgomery–Asberg Depression Rating Scale. Patients
in the past depression group had major depressive episode in the past but
were not considered currently symptomatic. aOther includes: Filipinos
(total three subjects, one in each group), two Aboriginal Canadians and
three women of mixed ethnicity (Caucasian-African). bNumber (no.) shown
includes the current pregnancy and baby.
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plate assignment, sample handling or cell purity) had bigger effect on
methylation levels than biological or pregnancy-related variables (such as
sex of newborns, gestational age, mode of delivery and maternal tobacco
use during pregnancy). Therefore, only the two most prominent technical
variables, plate assignment and cell purity, were included as covariates in
the depression association analyses. The other ﬁve possibly confounding
variables were tested afterwards by adding an additional variable—one at
a time—to the linear model.
As the probes on the Inﬁnium Human Methylation 450 K BeadChip Array
might contain single-nucleotide polymorphisms (SNPs) and also 6% of the
probes can possibly cross-hybridize to regions of the genome other than
their speciﬁc target,31 we screened our list of differentially methylated CG-
sites. For the screening, we used 29 233 potentially cross-hybridizing
probes and 53 892 probes with SNPs in the sequence of the probe or at the
site of single-base extension, which had allele frequency between 5 and
95% in the European population (based on 1000 Genomes project release
20110521, as indicated by Chen et al.31).
The genes containing differentially methylated CG-sites were classiﬁed
using the Ingenuity Pathway Analysis software (www.ingenuity.com).
Ingenuity Pathway Analysis identiﬁes the most signiﬁcant biological
functions, pathways and upstream regulators on the basis of a large
number of manually collected relationships between genes from the
scientiﬁc literature. A right-tailed Fisher’s exact test was used to calculate
the gene enrichment, and biological functions with Po0.05 signiﬁcance
level. Calculating the probability of overlaps was done by the R phyper
(hypergeometric distribution)32 using ENCODE data of H3K4me1 and
H3K4me3 regions in human PBMC (92 975 and 126 420 sites on the
Illumina Methylation 450 K array, respectively).
Analyses of methylation data from hippocampal tissue samples
Previously obtained33 DNA methylation proﬁles using methylated DNA
immunoprecipitation followed by array-hybridization of postmortem
hippocampal samples (dentate gyrus from the left hemisphere) of 62
adult males were analyzed according to presence (n=12) or absence
(n=50) of maternal depression. Psychiatric history (DSM-IV diagnoses from
SCID-I interviews), family history (assessed with Family Interview for
Genetic Studies)34 and demographic information of the deceased were
obtained via psychological autopsy performed by trained clinicians with
informants best acquainted with the deceased among their ﬁrst-degree
family members, as described earlier.35 This proxy-based assessment of
psychological autopsy has been extensively investigated and found to
produce valid information, demonstrating similar information obtained
from the informant and from the subject.35–38
A custom-designed 400 K promoter tiling array (Agilent Technologies,
Santa Clara, CA, USA) provided information about 23 551 gene promoters
(1200 bp upstream and 400 bp downstream of the transcription start sites
of genes) described in Ensembl version 55 (http://www.ensembl.org). The
details of the analyses are in Supplementary Information S1. A probe and
the containing promoter were called differentially methylated if the P-
value of the probe t-statistic was ⩽ 0.05, log2-fold change between the
groups was ⩾ 0.25 and the FDR was o0.1. The annotation of differentially
methylated regions to genes was done using the annotatePeaks.pl
program, part of the Hypergeometric Optimization of Motif EnRichment
annotation program.39
Pyrosequencing
Site-speciﬁc methylation analyses of BLK, FCER2, MGAT4A and TRIM34 gene
regions were performed by pyrosequencing using PyroMark Q24 or Q96
(Qiagen, Venlo, Limburg, The Netherlands). These gene regions were
selected on the basis of the following criteria: two or more neighboring
CG-sites were detected within 1000 bp of the gene transcription start site
and their change in methylation was at least 10% in the same direction. To
cover a broad range of methylation level, both lower and higher average
methylation level regions were chosen. The details of PCR ampliﬁcation
and primer sequences are in Supplementary Information S1.
RESULTS
Genome-wide DNA methylation analyses of T lymphocytes
We tested the effects of both lifetime (past history) and present
symptoms of depression. Therefore, two sets of comparison were
carried out in both the maternal and neonatal (cord blood)
samples: First we compared the two patient groups (the current
depression group or the past depression group) separately to the
control subjects. In the second set of analyses, we compared all
patients independent of actual symptom severity, that is, the
current depression and the past depression groups (so-called
lifetime depression group) vs control group. The demographic
variables did not differ signiﬁcantly between the groups except for
tobacco use during pregnancy (χ2(2) = 8.06; P= 0.018) and mode of
delivery (χ2(2) = 8.89; P= 0.012, for frequency data see Table 1).
However, in the lifetime depression vs control group setting none
of these variables differed signiﬁcantly (P-values 40.1), only the
depression severity scores differentiated the lifetime depression
group from the control group (Montgomery–Asberg Depression
Rating Scale P= 0.001, Edinburgh Postnatal Depression Scale
P= 2.4e− 4), even though only half of the patients had elevated
depression scores at the time of the assessment.
Analysis of the antepartum maternal T lymphocyte samples
showed no signiﬁcant difference in DNA methylation between
depression groups and controls: current depression group vs
control group; past depression group vs control group; or lifetime
depression group vs control group with FDR o0.1. None of the
depressive symptom severity scores (obtained at the antepartum
visit) showed correlation with T lymphocyte DNA
methylation level.
Analysis of the neonatal cord blood T lymphocytes identiﬁed
signiﬁcant differences in DNA methylation between maternal
depression and control groups, especially the combined maternal
current and past depression groups (hereafter referred to as the
maternal depression group) vs control group. Using a conservative
FDR threshold of 0.05, 163 CG-sites (145 sites after removal of 14
probes with possible SNP with frequency ⩾ 5% in Caucasians and
four potentially cross-hybridizing probes) were found to be
differentially methylated between the maternal depression group
and the control group in neonatal T lymphocyte DNA. Among the
145 differentially methylated CG-sites, there were 64 with more
than 5% difference between groups (see data in Supplementary
Information S2). Using a moderate FDR threshold of 0.1, 2857 CG-
sites (2520 sites after removal of potentially problematic probes)
were found to be differentially methylated. Among the 2520
differentially methylated sites, 75.5% were hypomethylated in the
maternal depression group compared with the control group
(Supplementary Information S3).
Because of the small sample size in this preliminary study, it was
not possible to adjust association model for all factors that may
affect DNA methylation, including, for example, newborn sex,40
gestational age,41 mode of delivery42 or maternal smoking during
pregnancy.43 Instead, we elected to include only two variables
with the largest effects on the data, plate assignment and cell
purity, in our models. To determine the robustness of the
associations to the effects of possibly confounding factors (such
as sex, gestational age, Cesarean section, maternal tobacco use
during pregnancy and sample handling), we tested each CG-site
association in a new model including each of these factors, one at
a time. For each CG-site, we identiﬁed the model with the least
signiﬁcant difference between the maternal depression and
control groups. All of the 145 differentially methylated sites at
FDR o0.05 in the original model had the least signiﬁcant
difference (largest P-value) o0.01, unadjusted for multiple
testing. Of the 2520 differentially methylated sites at FDR o0.1
in the original model, 1907 sites had P-values o0.05 and 518 sites
had P-values o0.01. Clearly, addition of these factors reduced
signiﬁcance, but we found that the majority of the CG-sites remain
associated with depression in the presence of potentially
confounding factors (for the P-values, see data in Supplementary
Information S3).
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Validation of CG methylation levels by pyrosequencing
To conﬁrm these results using Illumina Methylation 450 K
microarray data, pyrosequencing of neonatal cord blood T
lymphocyte DNA was performed in 54 individual samples at four
gene regions (BLK, FCER2, MGAT4A and TRIM34; Figure 1a). Overall,
the methylation level assessed by pyrosequencing was highly
correlated with the Illumina data (R= 0.96 on average, with values
for speciﬁc sites in the range of R= 0.91–0.98). Ten out of 11
selected CG-sites showed similar differences between the
maternal depression and control groups (for P-values of selected
sites in the four genes, see Figures 1b-e).
Enrichment analyses of differentially methylated sites in T
lymphocytes that are associated with maternal depression
A moderate FDR threshold of 0.1 was used to gain insight on a
larger scale of the genomic distribution of the DNA methylation
differences associated with maternal depression in neonatal
cord blood T lymphocytes. For the results of the Ingenuity
Pathway Analysis of the 2520 differentially methylated CG-sites
associated with 1943 genes, see Supplementary Information S6.A.
A comparison with H3K4me1 regions of human PBMC (ENCODE
data) showed a signiﬁcant enrichment of these differentially
methylated CG-sites in enhancers (1236 CG-sites, P= 7.6e− 249,
hypergeometric test) consistent with potential impact of the
DNA methylation differences on regulation of gene expression.
In contrast, we observed a negative enrichment in H3K4me3
regions (279 CG-sites, P= 1.2e− 79), associated with promoters
of active genes. Genes associated with the differentially methyl-
ated enhancers were enriched in biological functions related
to immune function such as ‘quantity of leukocytes’ (126 genes,
P= 6.3e− 22), ‘leukocyte migration’ (121 genes, P= 3.8e− 21),
‘activation of leukocytes’ (96 genes, P= 3.3e− 17), ‘differentiation
of leukocyte’ (92 genes, P= 1.1e− 16) and also in canonical
pathways such as CD28 or iCOS-iCOSL signaling in T helper
cells (19 genes, P= 5.4e− 7; and 18 genes, P= 6.3e− 7, respec-
tively). Moreover, these genes are potential regulators of
immune functions (for example, TNF—130 genes, P= 6.3e− 17;
lipopolysaccharide—126 genes, P= 9.3e− 14; IFNG—95
genes, P= 3.4e− 10; CSF3—26 genes, P= 1.2e− 9) or stress
(NR3C1—63 genes, P= 2.7e− 11, dexamethasone—119 genes,
P= 3.5e− 12).
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Figure 1. Pyrosequencing validation of differentially methylated CG-sites in T lymphocyte DNA from neonatal cord blood samples. (a)
Validation of Illumina Inﬁnium 450k methylation data for the indicated CG-sites across four genes. (b–e) Selected CG-sites of four genes with
signiﬁcant methylation differences between maternal depression and control groups in neonatal cord blood T lymphocyte samples measured
by Illumina microarray and pyrosequencing (BLK: B lymphoid tyrosine kinase; FCER2: Fc fragment of IgE, low afﬁnity II, receptor for CD23;
MGAT4A: N-acetylglucosaminyltransferase; TRIM34: tripartite motif containing 34). Dark green boxes indicate exons, light green boxes show
transcribed, non-coding regions. Alternative gene transcripts indicated by NCBI are shown in separate lines. The adjusted beta-values were
computed after removing technical artifacts, like plate assignment and sample purity.
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DNA methylation associations with maternal depression in adult
hippocampus
As lifetime maternal depression was associated with methylation
differences in the offspring T lymphocytes, previously obtained
methylation data sets of postmortem hippocampal brain samples
of adult men were analyzed according to a history of lifetime
maternal depression (for description of the samples and subjects,
see Table 2). Using the Hypergeometric Optimization of Motif
EnRichment annotation program,39 we found 294 differentially
methylated probes associated with 234 genes (Supplementary
Information S4). The gene set analysis showed enrichments in
immunological-related functions, such as ‘recruitment of blood
cells’ (16 genes, P= 1.7e− 7), ‘activation of microglia’ (seven genes,
P= 2e− 5) or in potential regulators, such as TGFBR2 (12 genes,
P= 1.3e− 7) or BCL6 (10 genes, P= 3.6e− 7; Supplementary
Information S6.B).
Overlap between DNA methylation signatures in neonatal cord
blood and adult brains
At last, we examined the overlap between the two sets of
differentially methylated genes using the FDR qo0.1 list of T
lymphocyte and hippocampus samples. As the two data sets were
acquired by different methods, only a small fraction of the Illumina
450 K array’s CG-sites were near the probes of the custom made
promoter array used for methylated DNA immunoprecipitation
analysis (211 Illumina CG-sites were located in the sequences of
the methylated DNA immunoprecipitation probes and 675
Illumina CG-sites were within 500 bases of the methylated DNA
immunoprecipitation probes), limiting the exact sequence com-
parisons. Nevertheless, we found 10 differentially methylated CG-
sites in T lymphocytes within 500 bases of differentially
methylated probes in the brain (bold numbers in Table 3). On
the gene level, the 2520 CG-sites differentially methylated (FDR
qo0.1) in the neonatal cord blood T lymphocytes were associated
with 1943 genes according to the Hypergeometric Optimization of
Motif EnRichment annotation program (Supplementary Table S3,
‘Gene.Name’ column). Of these genes, a signiﬁcant subset (n= 33;
P= 0.002, hypergeometric test) were also differentially methylated
in postmortem hippocampal samples from adult brains (Table 3,
also see Supplementary Information S5 for full list). These
overlapping genes were enriched for immune functions such as
‘differentiation of leukocytes’ (seven genes, P= 1.3e− 4) or had
potential upstream regulators such as IL2 (six genes, P= 6e− 5),
IFNG (eight genes, P= 1.2e− 4) and dexamethasone (eight genes,
P= 5.8e− 4).
DISCUSSION
The impact of maternal depression on offspring well-being is well
documented but the mechanisms are unclear. We examined here
the hypothesis that exposure to maternal depression has an
impact on DNA methylation in the offspring in T lymphocytes as
well as in the brain. Our study design allowed us to compare the
cross-generational impact of depression on DNA methylation level
genome-wide. Although we did not observe any signiﬁcant
changes associated with depression in T lymphocytes from the
antepartum maternal samples, our analysis revealed an associa-
tion between maternal depression and DNA methylation changes
in offspring CD3+ T lymphocytes at birth and in adult
hippocampal samples. Likely due to the increased power in the
analysis of any maternal depression compared with just past or
current depression, any maternal depression was associated with
many methylation changes in the cord blood samples, whereas
past or current maternal depression alone were associated with
few or no methylation changes.
The presence of a DNA methylation signature associated with
lifetime maternal depression prompted an examination of brain
samples of adult men with a history of maternal depression.
Similarly, there was no division according to the timing of
maternal depression at the postmortem hippocampal samples,
groups were compared on the basis of the presence or absence of
lifetime depression of the mothers. Interestingly, the pathway
analyses of the differentially methylated genes in the hippocam-
pal samples highlighted immunological functions, and the genes
overlapping between adult hippocampal and neonatal T lympho-
cyte associations were enriched for (neuro)immune functions. In
addition, at the upstream regulators of the overlapping genes,
dexamethasone was among the top hits after interleukin 2 and
interferon gamma, highlighting the potential effect of corticoster-
oids. Therefore, our analyses of DNA methylation data support the
idea that changes in DNA methylation can be observed in the
brain of adult offspring of depressed women, and that remarkably,
there is an overlap between DNA methylation alterations at birth
in T lymphocytes and in the adult hippocampus. These results
suggest that maternal depression may have long-lasting effects on
immune functions in the periphery as well as in the central
nervous system of the offspring, in line with the hypothesis that
the response in DNA methylation to behavioral exposures is
system-wide.9 This is consistent with previous studies that have
demonstrated changes in DNA methylation in T lymphocytes and
in the brain of nonhuman primates in response to early-life
maternal deprivation.44 As lifetime maternal depression was used
in the analyses (meaning that depressive symptoms of the
Table 2. Description of the brain samples, lifetime psychiatric disorder diagnoses and drug use of the subjects
Non-depressed mother (n= 50) Mother with depression (n= 12) P-value
Age (years) 39.3± 12.7 39.5± 9.9 0.960
Mean± s.d. (Range) (18–75) (26–51)
Reason of death
Accident 14 (28%) 2 (16.7%) 0.714a
Suicide 36 (72%) 10 (83.3%)
Brain pH
Mean± s.d. (Range) 6.51± 0.33 (5.5–7.0) 6.68± 0.15 (6.4–6.9) 0.009b
Postmortem interval (hours)
Mean± s.d. (Range) 33.1± 14.4 (12–67) 25.8± 12.9 (15–62) 0.115
Childhood abuse history 20 (40%) 5 (41.7%) 1.0a
Major depressive disorder 13 (26%) 7 (58.3%) 0.031
Bipolar disorder 4 (8%) 42 (16.7%) 0.328a
Alcohol misuse 23 (46%) 4 (33.3%) 0.427
Cannabis use 4 (8%) 1 (8.3%) 1.0a
Cocaine use 6 (12%) 0 0.586a
aFisher's exact test (one or two cells have expected count o5). bEqual variances are not assumed.
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mothers could be present during the prenatal and/or postnatal
periods), the underlying biological mechanisms of the DNA
methylation changes in the offspring are likely due to system-
wide alterations (such as altered stress reactivity, corticosteroid
effect) making women more prone to develop depression.
Cord blood samples have been previously used for DNA
methylation analyses in association with maternal mood disorders
or depressive symptoms in candidate gene,13,14 and genome-wide
approaches.45,46 These studies used either whole blood or
PBMCs. In our study, we used CD3+ T lymphocytes for assessing
cell-mediated immunity and to reduce confounding cell-type
speciﬁc differences present among leukocytes.47 Our ﬁndings
are similar to the results of the previous whole epigenome
analysis using Illumina Inﬁnium 450 K technology in cord blood
cells: The DNA methylation changes associated with maternal
depression in neonatal cord blood samples were small: in the
range of 1–9% reported by Non et al.45 and 2–10% in our study at
FDR qo0.05. The majority of differentially methylated CG-sites
were hypomethylated in the maternal depression group com-
pared with controls in both studies. These results are also in
accordance with previous candidate gene analyses where, for
example, 2–6% differences were observed at imprinted gene
regions17 or at the glucocorticoid receptor gene promoter
region13 in association with maternal depressive symptoms.
However, the number of the differentially methylated CG-sites
associated with maternal depression in T lymphocytes is much
higher in our study (2520 vs 42 CG-sites at FDR qo0.1). There
was no overlap in the indicated CG-sites of the two studies, but
there were ﬁve genes common out of the 38 genes in the
FDR-adjusted Po0.1 list reported by Non et al.45 More
importantly, one gene (TNS3) had two CG-sites in the list of Non
et al. and three genes (CBFA2T3, TNRC6C, TNS3) had two or three
CG-sites in our FDR qo0.1 list, supporting the notion that bigger
chromosomal regions are affected by DNA methylation changes.
The reason for the discrepancy in the number of affected CG-sites
might reﬂect our use of T lymphocyte sample instead of a mixture
of leukocytes.
DNA methylation is a binary signal; an allele could either be
methylated or unmethylated at a particular site. Thus, the
percentage change in DNA methylation indicates the fraction of
cells that had experienced a complete change in methylation at a
particular site. Our results indicate that the differences in
methylation associated with maternal depression do not occur
in all cells but in 5–10% of T lymphocytes, which might be
extremely important if a particular subtype is involved. Although
we tried to limit the heterogeneity of the cells, this cell population
is still heterogeneous in terms of functionality (see for example,
CD4+ T helper and CD8+ T killer cells).48 An exciting challenge that
should be addressed in future studies is identifying the particular
subtype of cells that are sensitive to exposure and undergo
changes in DNA methylation. As the majority of changes in
response to maternal depression were decreased methylation
level, it is plausible to hypothesize that certain inﬂammatory
pathways of speciﬁc T lymphocytes get activated in the blood (see
indicated pathways of cord blood T cells in Supplementary
Information S6.A, such as quantity and migration of leukocytes).
The increased leukocyte migration and activation of microglia in
the brain tissues (see pathways of hippocampi in Supplementary
Information S6.B) could potentially affect neurogenesis in the
critical window of perinatal development. However, this hypoth-
esis requires further experiments in animal models as it is
impossible to test in humans.
The main limitations of our study were the comparatively small
sample sizes and that there were differences between groups for a
couple of demographic variables that might affect DNA methyla-
tion. For example, maternal tobacco use during pregnancy has
been shown to affect cord blood DNA methylation level at 10
genes.43 Interestingly, three of the genes associated with maternal
smoking (AHRR, GFI1, TTC7B) were present among the 1943
differentially methylated genes in the cord blood samples at FDR
qo0.1 level in our study. However, the indicated CG-sites did not
overlap, and none of these genes was detected among the 139
genes associated with maternal depression in the cord blood
samples at FDR qo0.05 level. Cesarean section, gender and
gestational age have also been reported to affect DNA methyla-
tion at speciﬁc CG-sites across the genome.40–42 Therefore, we
have checked the effects of ﬁve potentially confounding variables
at the CG-sites identiﬁed as differentially methylated by adding
each variable, one at a time, to our linear models and retesting
signiﬁcance. All of the 145 differentially methylated sites (FDR
o0.05) and the majority of the 2520 CG-sites (FDR o0.1)
remained signiﬁcantly different between depressed and control
groups across the models.
Another limitation of our study is that we preselected CG-sites
with at least 10% methylation variance across the samples to
reduce the number of association tests. In this way, we might have
preselected CG-sites inﬂuenced by genetic variation. To solve this
problem, we screened out probes containing common SNPs in our
study population (genetic variants with at least 5% allele
frequency among Caucasians as indicated by the 1000 Genome
data, see Materials and methods). In this way, common genetic
variants at the CG-sites (meSNPs) and within 50 bases from the
CG-sites were screened out (9% of the differentially methylated
sites were removed). This screen should remove two-thirds of the
strongest cis-acting methylation-associated loci (cis-meQTLs).49
At the brain samples, there was only one signiﬁcantly different
variable between the two groups: adult offspring of depressed
women were more frequently diagnosed with major depressive
disorder themselves (58 vs 26%, P= 0.031; Table 2). However, there
were no signiﬁcant differences in childhood abuse, suicide or drug
use history, which have been previously shown to affect DNA
methylation patterns.33,50 Another limitation in the analyses of the
brain samples was that the methylation data were obtained by a
technique that only measures gene promoters, thus limiting the
number of overlapping CG-sites in the neonatal T lymphocyte
DNA Illumina 450 K array data set that could be examined.
In conclusion, our preliminary data set of the cord blood
samples allowed us to detect differentially methylated sites
associated with maternal depression at birth. The supportive data
of the adult brain samples show that maternal depression has an
effect on epigenetic programming in the offspring, which may
persist into adulthood, and detectable in the hippocampus.
Independent studies using larger number of blood samples are
needed to conﬁrm our results.
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